Reducing the risk of heart disease in people with breast cancer

Not Applicable

• Conditions: breast cancer; cardiovascular disease; Cancer - Breast; Cardiovascular - Coronary heart disease

• Registration Number: ACTRN12620000439943
• Lead Sponsor: Flinders University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-04-06
• Last Update Posted: 14 April 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Key inclusion criteria are:
(a) adults (aged over 18 years)
(b) have sufficient English language ability to provide informed consent (assessed via approaching clinician upon approach)
(c) newly diagnosed with breast cancer or diagnosed within the past 6 months
(d) life expectancy of one year or more (according to the treating oncologist’s estimate)

Exclusion Criteria

Patients will be excluded if they are assessed by the approaching clinician to have:
(a) clinically significant/elevated distress, or
(b) significant cognitive impairment that may impact ability to give informed consent or participate effectively, or
(c) to be too unwell to comfortably participate (e.g. end stage disease).
No other exclusion criteria will apply.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Feasibility, measured as adherence to the pathway and care plan (appointment, review, adherence to recommended interventions and referrals). [3 months after initial assessment and initiation of the pathway. ]